Cheerleaders for diabetes heavyweight Novo Nordisk have been reassured by positive topline data from a Phase II trial of its semaglutide plus cagrilintide candi 22 August 2022
US President Joe Biden looks set to secure a major legislative win that could affect drug pricing in the country, as the Inflation Reduction Act narrowly won Se 8 August 2022
US drugmaker Eli Lilly was trading more than 3% lower by the early afternoon on Thursday after presenting its financial results for the second quarter of 2022, 4 August 2022
Arecor Therapeutics, a globally focused biopharmaceutical company advancing today's therapies to enable healthier lives, has announced that it has entered into 1 August 2022
Japanese drugmaker Mitsubishi Tanabe Pharma Corporation (TYO: 4508) is to sell US pharma major Eli Lilly’s diabetes drug tirzepatide in Japan following an agree 8 July 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.